Bill Haney's Sky­hawk spears an­oth­er mar­quee al­liance for its work drug­ging RNA in Take­da neu­ro pact

Bill Haney’s Sky­hawk Ther­a­peu­tics has scored an­oth­er high-pro­file de­vel­op­ment part­ner.

Com­ing af­ter its Shire buy­out, Take­da has al­lied with Sky­hawk to dis­cov­er new small …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER